3,4-Dichloro-a-[[[(3-methoxyphenyl)methyl]methylamino]methyl]-benzenemethanol D3

3,4-Dichloro-a-[[[(3-methoxyphenyl)methyl]methylamino]methyl]-benzenemethanol D3, commonly referred to as D3, is a chemical compound with a molecular formula of C19H23Cl2NO2. It is a potent and selective dopamine D3 receptor antagonist that has been used in various research studies to investigate the role of dopamine in the brain and its connection to various neurological disorders. D3 is typically administered through injection or ingestion and has a half-life of approximately 10 hours in humans. It is primarily used in preclinical studies to evaluate its potential therapeutic effects on various neuropsychiatric disorders, including schizophrenia, drug addiction, and Parkinson's disease. The chemical structure of D3 includes two chlorine atoms and a methoxy group, which are responsible for its potent dopamine receptor-blocking properties. It is essential to note that due to its potent effects on dopamine receptors, D3 should only be used under the supervision of trained professionals in a controlled laboratory setting. In conclusion, D3 is a potent dopamine D3 receptor antagonist that has been used in various preclinical studies to investigate the role of dopamine in various neuropsychiatric disorders. Its chemical composition includes two chlorine atoms and a methoxy group, which are responsible for its potent effects on dopamine receptors. However, it should only be used in a controlled laboratory setting under the supervision of trained professionals.